Trial
NCT00696592
Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular Degeneration
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Padova
Collaborators
Department of Ophthalmology, Conegliano Hospital, Treviso, Italy
Condition
Neovascular Age-related Macular Degeneration
Intervention
Bevacizumab (Avastin), Verteporfin (Visudyne)
Why stopped
new data from clinical trials
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-24